MLYS - Mineralys Therapeutics, Inc.
28.43
1.190 4.186%
Share volume: 3,587,124
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$27.24
1.19
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-12-2024 | 02-12-2025 | 05-12-2025 | 11-10-2025 | |
| Cash flow financing | 116.205 M | -152.000 K | -1.000 K | 90.000 K | 189.279 M | 295.188 M | |
| Other financing cash flows | 149.000 K | 54.000 K | 40.000 K | 54.000 K | 123.000 K | 6.624 M | |
| Cash flow | 41.114 M | -22.562 M | 29.418 M | 16.817 M | 50.916 M | 115.809 M | |
| Net income | -31.508 M | -41.014 M | -56.342 M | -48.946 M | -42.211 M | -36.932 M | |
| Depreciation | 8.000 K | 9.000 K | 11.000 K | 15.000 K | 15.000 K | 15.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -55.952 M | 7.736 M | 79.605 M | 83.570 M | -92.876 M | -150.507 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 59.000 K | 0.000 | 37.000 K | 0.000 | 0.000 | 0.000 | |
| Cash Change | 41.114 M | -22.562 M | 29.418 M | 16.817 M | 50.916 M | 115.809 M |